Presence and quantification of neuropeptide Y in pulmonary edema fluids in rats

Experimental Lung Research

Volumn 26, Issue 3, 2000, Pages 137-147

  Hamdy, Ossama ^a   Nishiwaki, Kimitoshi ^b   Yajima, Michio ^c   Murakami, Hidetsugu O ^c   Maekawa, Hiroshi ^c   Moy, Robert T ^d   Shimada, Yasuhiro ^a   Hotta, Yoshihiro ^c   Ishikawa, Naohisa ^c,e  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

ELISA; Immunohistochemistry; Neuropeptide Y; Pulmonary edema

Indexed keywords

FIBRINOGEN; NEUROPEPTIDE Y; THROMBIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYDROSTATIC PRESSURE; IMMUNOHISTOCHEMISTRY; LUNG EDEMA; LUNG HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE DIAGNOSIS; RAT;

EID: 0034057296     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/019021400269835     Document Type: Article

References (20)

1. 1. Crystal RG, Barnes PJ, West JB, Weibel ER: The Lung. Philadelphia: Lippincot-Raven; 1997.
2. 2. Minner FL, Malik AB: Mechanisms of neurogenic pulmonary edema. Ann NY Acad Sci. 1982;384:169-190.
3. 1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation. Eur J Pharmacol. 1997;329:79-83.
4. 4. Gulbenkian S, Saetrum Opgaard O, Ekman R, Andrade CN, Wharton J, Polak J, Queiroz e Melo MJ, Edvinsson L: Peptidergic innervation of human epicardial coronary arteries. Circ Res. 1993;73:579-588.
5. 5. Saetrum Opgaard O, Gulbenkian S, Bergdahl A, Barroso CP, Andrade CN, Polak JM, Queiroz e Melo J, Edvinsson L: Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility. Cardiovasc Res. 1995;29:463-468.
6. 6. Van der Zee H, Malik AB, Lee BC, Hakim TS: Lung fluid and protein exchange during intracranial hypertension and role of sympathetic mechanisms. J Appl Physiol. 1980;48:273-280.
7. 7. Sakakibara H, Hashiba Y, Taki K, Kawanishi M, Shimada Y, Ishikawa N: Lung vascular permeability enhanced by sympathetic nerve stimulation in rats. Jpn J Pharmacol. 1991:56:391-395.
8. 8. Sakakibara H, Hashiba Y, Taki K, Kawanishi M, Shimada Y, Ishikawa N: Effect of sympathetic nerve stimulation on lung vascular permeability in the rat. Am Rev Respir Dis. 1992; 145:685-692.
9. 9. Hirabayashi A, Nishiwaki K, Shimada Y, Ishikawa N: Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. Eur J Pharmacol. 1996;296:297-305.
10. 10. Ishikawa N, Kainuma M, Furuta T, Sato Y: Factors influencing fibrin-induced pulmonary edema. Jpn J Pharmacol. 1988;46:255-260.
11. 11. Hashiba Y, Ishikawa N, Sumita T, Takagi K, Hidaka H, Satake T: Capsaicin-sensitive nerves exert an inhibitory effect on the development of fibrin-induced pulmonary edema in rats. Am Rev Resp Dis: 1989;140:652-658.
12. 12. Snedecor GW, Cochran WG: Statistical Methods. Iowa: Iowa State University Press; 1967.
13. 13. Rascher W, Kremens B, Wagner S, Friedheim F, Hunneman DH, Lang RE: Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. J Pediatr. 1993; 122:914-916.
14. 14. Morris MJ, Cox HS, Lambert GW, Kaye KM, Jennings HL, Meredith IT, Esler MD: Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension. 1997;29:137-143.
15. 15. Sonea IM, Bowker RM, Robinson NE, Broadstone RV: Distribution of dopamine beta-hydroxylase and neuropeptide Y immunoreactive nerves in healthy equine lungs. Am J Vet Res. 1993;54:507-513.
16. 16. Carlson RW, Schaeffer RC Jr, Michaels SG, Weil MH: Pulmonary edema fluid: spectrum of features in 37 patients. Circulation. 1979;60:1161-1169.
17. 17. Fein A, Grosman RF, Jones JG, Overland E, Pitts L, Murray JF, Staub NC: The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med. 1979;67:32-38.
18. 18. Hirabayashi A, Nishiwaki K, Shimada Y, Ishikawa N: Effects of neuropeptide Y on lung vascular permeability in the pulmonary circulation of rats. Eur J Pharmacol. 1994;256:227-230.
19. 1 -receptor antagonist, BIBP 3226. Br J Pharmacol. 1995;116-.2971-2982.
20. 20. Betancur C, Azzi M, Rostene W: Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Pharmacol Sci. 1997;18:372-386.